Home › ForteBio Launches Dip And Read Anti-Human Fab-CH1 Biosensor To Accelerate Human Biotherapeutic Drug Development
 

Keywords :   


ForteBio Launches Dip And Read Anti-Human Fab-CH1 Biosensor To Accelerate Human Biotherapeutic Drug Development

2013-01-09 18:00:00| drugdiscoveryonline News Articles

ForteBio, a division of Pall Life Sciences and a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, recently announced the launch of its Dip and Read Anti-Human Fab-CH1 biosensor

Tags: read development human drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Registration Now Open for RadTech 2025
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Public Advisory Number 7A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Vodafone-Three merger could get green light, watchdog says
05.11Altice USA residential video RGUs down 77,000 in 3Q 2024
More »